The Radiotherapy and Oncology Clinic has reported the arrival of necessary oncological treatment supplies, resolving previous concerns regarding resource scarcity for certain specialized care, as noted by the association “Hema-Onk.” The Clinic confirmed that there will be no discount applied to the treatment costs until the remaining portion of the therapy arrives within the next two days. Previously, there was a reported lack of specialized treatment options for patients diagnosed with jaw cancer, including regimens for full-fledged care, Zaleks, and Ribociclib. Furthermore, the lack of specific therapy for the positive list—a component of care for patients with jaw and thymus cancer—has also been addressed.
According to Clinic representatives, the necessary therapy for the positive list has arrived, ensuring that patients will be among the first to receive it. A spokesperson advised patients to remain calm and avoid unnecessary anxiety, emphasizing that the immediate availability of these resources is a positive development for the oncology community. The arrival of these materials significantly mitigates the prior concern over resource limitations, allowing the Clinic to proceed with comprehensive care plans for all affected patients.
Topics: #treatment #patients #lack
